May 27, 2022 | Supply Chain Strategy
The Russia-Ukraine war is entering its fourth month, and its impact continues to spread across industries and sectors of the global economy. Combined with rising inflation and the ongoing COVID-19 pandemic, companies are feeling the pinch from supply chains now burdened with new costs.
Yet while it might be a cliché, there’s an opportunity lying behind those challenges.
May 27, 2022 | Procurement Strategy
The consumer-packaged goods industry is facing significant pressures already this year: high inflation, supply shortages for energy and commodities and increasing requirements on sustainability from consumers and governments alike. Costs are increasing across the board.
What can CPG companies do to mitigate the impact of these challenges to stay competitive and meet rising expectations from investors, consumers and governments?
May 10, 2022 | Marketing
Desperate times often call for desperate measures, like the ongoing electronic component crisis, especially the chip shortage.
An industrial conglomerate reportedly bought washing machines for the semiconductors inside to use them in its own chip modules.
April 08, 2022 | Logistics
BNSF, a U.S. railroad company, some months ago proposed demurrage fees due to the worsening shortage of 53-foot chassis equipment in various locations such as Dallas, Phoenix and Stockton, California.
April 07, 2022 | Supply Chain Software
Finding ways to counter supply chain disruption and building resilience are the top priorities for businesses today. In this endeavor, however, many organizations have not walked the talk.
In fact, there still are glaring gaps in procurement and supply chain processes that present greater risks in today’s uncertain business environment.
The global pandemic and a cascading series of disruptions have fundamentally altered supply chain and procurement operations, and many companies were ill-equipped to adapt to an altered landscape. Now, new research shows that there may be an underlying misalignment in the response: a disconnect between supply chain and procurement operations, and a disconnect between these practices and the enterprise on strategic priorities.
What’s the impact, and what can be done to fix it?
February 12, 2022 | Healthcare
Contract manufacturers for pharmaceutical companies continue to adjust to the disruptions brought about by the COVID-19 pandemic.
Clinical trials delayed due to the pandemic are kicking-off again, along with new trials that were in the pre-clinical phase. The manufacturers are now balancing the demand for COVID-19 as well as non-COVID-related therapies.
Turn ideas into action. Talk to GEP.
GEP helps enterprise procurement and supply chain teams at hundreds of Fortune 500 and Global 2000 companies rapidly achieve more efficient, more effective operations, with greater reach, improved performance, and increased impact. To learn more about how we can help you, contact us today.
Amol Jawale
Vice President, Consulting
Amol is responsible for leading global teams and building long-lasting strategic client relationships for GEP’s Fortune 500 Pharma & Life Sciences clients.
He has vast experience in leading engagements focused on procurement strategy, delivery management, and competitive assessment and formulating business cases with C-Suite stakeholders to enable sustainable value creation.
